Journal of Lung Cancer Epidemiology

Journal of Lung Cancer Epidemiology

Journal of Lung Cancer Epidemiology – Aim And Scope

Open Access & Peer-Reviewed

Submit Manuscript

Aims & Scope

The Journal of Mammal Research publishes rigorous population-level research examining the distribution, determinants, and prevention of lung cancer across diverse populations, with emphasis on surveillance methods, risk factor analysis, and public health interventions.

Population Health Disease Surveillance Risk Modeling Prevention Strategies Health Disparities

Research Domains

Tier 1: Core Focus Areas

Epidemiologic Surveillance & Trends

  • Incidence and mortality patterns across populations
  • Geographic and temporal trend analysis
  • Cancer registry data quality and methods
  • Survival analysis and prognostic modeling
  • Age-period-cohort modeling
  • Burden of disease assessments
Typical Fit Example:

"Temporal trends in lung cancer incidence among never-smokers in East Asia: A population-based registry analysis, 2000-2020"

Risk Factor Epidemiology

  • Tobacco exposure assessment and dose-response
  • Secondhand smoke and environmental tobacco
  • Occupational carcinogen exposure (asbestos, radon, silica)
  • Air pollution and particulate matter
  • Dietary and lifestyle factors
  • Gene-environment interactions
Typical Fit Example:

"Occupational diesel exhaust exposure and lung cancer risk: A nested case-control study in transportation workers"

Molecular & Genetic Epidemiology

  • Genetic susceptibility and familial aggregation
  • Genome-wide association studies (GWAS)
  • Population-level biomarker validation
  • Polygenic risk score development
  • Epigenetic modifications in populations
  • Pharmacogenomics and population response
Typical Fit Example:

"Polygenic risk scores for lung cancer prediction in multi-ethnic cohorts: Validation and clinical utility assessment"

Prevention & Screening Epidemiology

  • Screening program effectiveness and outcomes
  • Low-dose CT screening implementation
  • Risk-based screening strategies
  • Tobacco cessation program evaluation
  • Primary prevention policy impact
  • Cost-effectiveness of interventions
Typical Fit Example:

"Population-level impact of lung cancer screening implementation: A natural experiment using national registry data"

Tier 2: Secondary Focus Areas

Health Disparities Research

Socioeconomic, racial/ethnic, and geographic inequalities in lung cancer burden, access to screening, and survival outcomes across populations.

Methodological Innovation

Novel statistical methods, causal inference approaches, machine learning applications for risk prediction, and big data analytics in lung cancer epidemiology.

Policy Evaluation

Assessment of tobacco control policies, environmental regulations, occupational safety standards, and healthcare policy impacts on population-level outcomes.

Global Health Perspectives

International comparisons, low- and middle-income country studies, migration and lung cancer risk, and cross-cultural epidemiologic patterns.

Tier 3: Emerging Areas

E-cigarette Epidemiology

Population-level studies of vaping prevalence, long-term health effects, and regulatory impact on lung cancer risk trajectories.

Climate Change & Lung Cancer

Environmental exposures related to climate change, wildfire smoke, and changing air quality patterns affecting lung cancer epidemiology.

Precision Prevention

Population implementation of risk-stratified prevention strategies, personalized screening algorithms, and targeted intervention programs.

Note: Emerging area submissions undergo additional editorial review to ensure population-level focus and epidemiologic rigor. Pilot studies and preliminary findings are encouraged if methodologically sound.

Article Types & Editorial Priorities

Priority 1

Fast-Track Review

Priority 2

Standard Review

Rarely Considered

Exceptional Circumstances Only

Editorial Standards & Requirements

Reporting Guidelines

STROBE for observational studies, PRISMA for systematic reviews, CONSORT for trials, RECORD for routinely collected data

Data Transparency

Data sharing statement required. Code and analysis scripts encouraged. Public data repositories preferred when feasible.

Ethics Compliance

IRB/ethics committee approval required for human subjects research. Informed consent documentation. GDPR compliance for EU data.

Preprint Policy

Preprints welcomed on recognized servers (medRxiv, bioRxiv). Does not affect consideration. Must be disclosed at submission.

Decision Metrics

We are committed to efficient, transparent editorial processes that respect authors' time and effort.

21 days
Median Time to First Decision
28%
Acceptance Rate
45 days
Acceptance to Publication
Open
Article Processing Charge
Questions about scope? Contact the editorial office before submission. We provide pre-submission inquiries within 5 business days to help authors determine fit. Email: [email protected]